United States· US:50228-431_bbb2d8e3-70b5-78f2-e053-2995a90a285e
Droxidopa
A droxidopa product containing droxidopa, registered in United States by ScieGen Pharmaceuticals Inc. The same ATC class is registered in 4 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Droxidopa is registered in 4 of 19 countries.
Countries holding a registration under ATC C01CA27 (droxidopa), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Droxidopa · ATC C01CA27
4 / 19 countries
- Japan
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DROXIDOPA
- Manufacturer
- ScieGen Pharmaceuticals Inc
- Country
- United States (US)
- ATC code
- C01CA27
- ATC class
- Droxidopa
- Defined daily dose
- 1 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc115022843105500 CAPSULE in 1 BOTTLE (50228-431-05)
- ndc11502284313030 CAPSULE in 1 BOTTLE (50228-431-30)
- ndc11502284319090 CAPSULE in 1 BOTTLE (50228-431-90)
- ndc1150228-431-05
- ndc1150228-431-30
- ndc1150228-431-90
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
47 interactions on record for droxidopa.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Droxidopa · interactions on record
47 records
- 2 severe
- 45 moderate
Most severe, free to view
- CocaineN01BC01severe
- CocaineR02AD03severe
- EpinephrineA01AD01moderate
- IsomethepteneA03AX10moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Droxidopa in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d45585a3-31f4-41a3-b7cb-ac2dc0229607 GET /v1/drugs/d45585a3-31f4-41a3-b7cb-ac2dc0229607?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "300",
"substance": "DROXIDOPA",
"productndc": "50228-431",
"dosage_form": "CAPSULE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA214017",
"marketing_category": "ANDA"
}See everything about droxidopa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.